0535-5133

S0535-51332021000100073

10.22209/ic.v62n1a07

Venezuela

31 03 2021

62 1 73 95

2001 344 23 23

1773-9

Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders of the Scientific Standardization Committee of the International Society on Thrombosis and Hemostasis

2014 12 11 11

1935-9

WFH Guidelines for the Management of Hemophilia panelists and co-authors

2020 3rd

Data and Demographics Committee of the World Federation of Hemophilia

2019 171 8 8

540-6

Ped-Net Study Group

2019 134 3 3

317-20

2019 102 2 2

111-22

PedNet study group

2020

PedNet and Research of Determinants of INhibitor development (RODIN) Study Group

2013 121 20 20

4046-55

2016 374 21 21

2054-64

2016 22 ^s4 ^s4 4

P65

2018 24 2 2

211-20

2020 4 ^s1 ^s1 1

2017 129 24 24

3147-54

WHO Hereditary Diseases Programme 1990

Inter Disciplinary Working Group

2008 14 2 2

361-74

2018 24 6 6

2016 14 5 5

1105-9

MUSFIH Study group

2017 23 4 4

538-46

2019 134 11 11

880-91

International Prophylaxis Study Group Pharmacokinetics Expert Working Group

2011 17 1 1

2-10

2017 15 12 12

2461-5

2014 20 1 1

2017 23 1 1

77-81

2015 125 13 13

2038-44

2018 24 3 3

International Prophylaxis Study Group (IPSG)

2018 24 6 6

845-8

2015 41 8 8

838-48

2014 1 1

355-63

A-LONG Investigators

2014 123 3 3

317-25

2015 6 6

967-77

2016 22 1 1

72-80

2019 25 ^sS1 ^sS1 S1

B-LONG Investigators

2013 369 24 24

2313-23

2017 4 2 2

2020

2020 4 ^s1 ^s1 1

2020

PROLONG-9FP Investigators Study Group

2016 127 14 14

1761-9

PROLONG-9FP Investigator Study Group

2016 116 4 4

659-68

2020 120 4 4

599-606

2015 126 9 9

1078-85

2017 23 2 2

238-46

2017 15 3 3

411-9

2019 25 6 6

1011-9

Pathfinder™2 Investigators

2017 117 2 2

252-61

2019 25 3 3

373-81

2017 117 9 9

1705-13

2011 118 10 10

2695-701

paradigm 2 Investigators

2014 124 26 26

3880-6

2016 14 8 8

1521-9

2020 26 3 3

2017 17 12 12

1573-80

2016 22 3 3

374-80

2018 24 4 4

595-603

AFFINITY Investigators

2016 128 5 5

630-7

2017 15 4 4

636-44

2020 135 17 17

1484-96

2020 383 11 11

1018-27

2020 111 1 1

20-30

2020

2020 136 6 6

740-8

2020 28 4 4

446-54

2017 377 9 9

809-18

2019 134 24 24

2127-38

2018 379 9 9

811-22

2019 6 6 6

2019 25 6 6

979-87

2017 130 23 23

2463-8

2019 35

43-50

2020 4 4 4

446-54

2020

2019 17 8 8

1269-72

2017 377 9 9

819-28

2018 16 11 11

2184-95

2019 134 22 22

1973-82

2019 25 5 5

797-806

2019 25 6 6

911-8

2018 16 10 10

1984-93

2019 12 1 1

21-8

2019 102 2 2

111-22

2012 119 6 6

1335-44

2017 23 5 5

654-9

Future of Immunotolerance Treatment Group

2019 25 4 4

676-84

2020

2020 382 1 1

29-40

2014 371 21 21

1994-2004

2017 377 23 23

2215-27

2019 3 21 21

3241-7

2019 25 5 5

738-46

2020

2020 26 4 4

591-600